pharmaphorum

JANUARY 13, 2023

Ultimately, we are going to see these therapies proliferate and the industry figure out how to execute them efficiently. And it’s the wrong target,” said Philippe Lopes-Fernandes, executive VP and chief business officer at Ipsen. On the other hand, the executive branch in the form of the FDA receives a more mixed review.

Drug Pricing 98

Drug Pricing Immunity Immunization Vaccines 98

FDA Law Blog: Biosimilars

OCTOBER 10, 2023

Information about these typical non-clinical tests is generally based on previously released guidance documents for each topic, as linked above. The totality of information helps inform FDA’s decision when it considers the overall benefit-risk profile of the implant device.

Documentation 45

Documentation Labelling Communication 45

Viseven

NOVEMBER 17, 2022

These medical affairs teams derive their value from high-profile medical expertise and provide efficient evidence of pharmaceutical products and medical devices. They also execute drug outcome studies and support healthcare brands. . The post Complete guide on pharmaceutical medical affairs appeared first on Viseven.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 52

Express Pharma

NOVEMBER 3, 2023

She also briefly touched on how technologies like intelligent process automation and generative AI are getting increasingly embedded applications to deliver better business process execution. Confirming this trend, Prakash Gupta, President, Global Supply Chain, Wockhardt said, “We learn a lot from the consumer.”

Packaging 107

Packaging Dosage Communication 107

pharmaphorum

APRIL 15, 2021

Bringing them together ensures key topics are brought to the forefront of conversations, enabling us to navigate and co-define the path forward, explains Schutte. Stef Schutte is executive vice president and head of the Regulatory Affairs function worldwide and is based in Leiden in the Netherlands. ” About the interviewee.

Labelling 76

Labelling Communication Pharmaceutical Manufacturing Pharmaceutical Companies 76

European Pharmaceutical Review

JANUARY 16, 2023

Another major topic covered by the experts was technological advances. According to Tim Sandle, new technologies mean: “The skill profile of the ‘traditional microbiologist’ is altering…”, affecting microbiologists working in the modern pharmaceutical microbiology lab.

Vaccines 127

Vaccines Research Laboratories Documentation Compounding 127

PharmaShots

MARCH 6, 2023

In combination with data-driven insights generation, our multi-faceted approach toward truly understanding patient needs will enable our teams to design and execute development plans for products that effectively address unmet needs. Clinical trials are a key topic for these interactions.

Drug Development 40

Drug Development Immunity Immunization Pharmaceutical Companies 40

Pharma Marketing Network

JUNE 8, 2020

RJ (PMN): Hi this is RJ Lewis, your host of the pharma marketing network podcast and I’m excited today to have with me a couple of executives from Klick Health to talk about CCPA. So, it’s about a person but more about behavioral profiling where we can target the right person based on their need. Welcome to the podcast!

HIPAA 40

HIPAA Pharmaceutical Companies Pharmaceutical Companies Communication 40

PharmaShots

FEBRUARY 27, 2023

Mr. Mekala Rao The topic discussed by Mr. Mekala was Metaverse: Healthcare and its role in this Game changing Technology. Dr. Addepalli Veeranjaneyulu and Shubhadeep Debabrata Sinha introduced the session by describing the function of PV in the safety profiles of biosimilars. So, people have neglected it that’s what I would say.”

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

pharmaphorum

JANUARY 12, 2021

It’ll also reveal just what the Target Development Profile (TDP) living document will cover and how it can evolve over time. Pulling all this work together will also be a test of NICE’s 2020 appointed chief executive Gillian Leng. This rolling review features is also another new element on offer under ILAP. The Netflix approach.

Documentation 82

Documentation 82